Lv1
50 积分 2023-04-27 加入
The current status of multimodality treatment for unresectable locally advanced esophageal squamous cell carcinoma
3天前
已完结
Current and future perspectives in unresectable locally advanced esophageal squamous cell cancer (Review)
3天前
已完结
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
3个月前
已完结
Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?
8个月前
已完结
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
8个月前
已完结
Nomogram update based on TAILORx clinical trial results - Oncotype DX breast cancer recurrence score can be predicted using clinicopathologic data
9个月前
已完结
Cadonilimab: First Approval
10个月前
已完结
Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary
10个月前
已完结
Good response of cadonilimab (PD-1/CTLA-4 Bi-specific antibody) to patients with advanced lung adenocarcinoma after immunotherapy resistance: A case report
11个月前
已完结
Immunotherapy rechallenge of advanced lung adenocarcinoma with cardonilimab (PD-1/CTLA-4 Bi-specific antibody): a case report
11个月前
已完结
皖公网安备34019202002308
